Fast-track pneumonia pathway focusing on early progressive mobilisation: a clinical feasibility study by Clausen, Lise Notander et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Fast-track pneumonia pathway focusing on early progressive mobilisation: a clinical
feasibility study
Clausen, Lise Notander; Børgesen, Mette; Ravn, Pernille; Møller, Tom
Published in:
 ERJ Open Research
DOI:
10.1183/23120541.00012-2019
Publication date:
2019
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY-NC
Citation for published version (APA):
Clausen, L. N., Børgesen, M., Ravn, P., & Møller, T. (2019). Fast-track pneumonia pathway focusing on early
progressive mobilisation: a clinical feasibility study. ERJ Open Research, 5(1), 00012-2019.
https://doi.org/10.1183/23120541.00012-2019
Download date: 03. Feb. 2020
Fast-track pneumonia pathway focusing
on early progressive mobilisation:
a clinical feasibility study
To the Editor:
Pneumonia and lower respiratory tract infection are the most common reasons for acute hospital
admission in Denmark [1], with an incidence of 3.1 cases per 1000 inhabitants [2]. Various European
studies report a substantial mortality rate of 5–15% among admitted patients following pneumonia.
Pneumonia affects people of all ages across all sociodemographic profiles, with greater risk in frail, older
individuals [3]. Often, patients are characterised by multiple comorbidities, low levels of function, reduced
energy intake, cognitive impairment and depression [4]. In addition, acutely admitted elderly patients are
exposed to prolonged bedrest and immobilisation, causing further physical deterioration [5].
The present feasibility study, inspired from the surgical fast-track pathways [6], aimed to investigate
whether patients with community-acquired pneumonia may be suitable for a fast-track pneumonia
pathway (FTPP) to support early progressive mobilisation as a mandatory systematic part of treatment
(figure 1a). The FTPP is a practical clinical worksheet that: supports clinician decision making on, for
example, the need for intravenous antibiotics; and coordinates monitoring and care according to the
existing national pneumonia guidelines. The basis of the FTPP is to reduce unnecessary treatment that
may delay or impede early progressive mobilisation. Moreover, using an objective physiological
measurement tool, we were able to detect mobilisation, physical activity and sedentary time during
hospitalisation and 10 days following discharge. We included patients aged >18 years with a radiologically
verified pneumonia consecutively recruited from the medical acute ward. Inclusion was applied to new
patients acutely admitted within the past 24 h. Exclusion criteria were pre-illness inability to walk with a
walking aid, inability to speak Danish, and confusion or cognitive dysfunction that prohibited informed
consent and the ability to cooperate with wearing the accelerometer.
During hospitalisation, 24-h mobility was measured using accelerometers (GT9X Link; ActiGraph,
Pensacola, FL, USA) placed at the right hip. Quantified as time (in hours) spent lying, sitting and
standing, mobility was analysed using ActiLife software (ActiGraph) in addition to steps per hour. The
nurse registered mobility on the standardised mobilisation care plan, which was used to document
patients’ mobilisation and physical activity during hospitalisation and irrespective of study participation.
The patient’s ability to perform various activities of daily living was assessed using the Barthel Activities of
Daily Living Index (BI-100) [7]. The five-dimension, five-level EuroQol (EQ-5D-5L) scale [8] and the
12-item Short Form Survey (SF-12) [9] were used to assess participants’ experiences of their own health
upon admission, discharge and follow-up.
Due to the nature of the feasibility design, descriptive statistics were used to describe the characteristics of
the study population and outcomes. Study inclusion was based on ethical requirements for giving oral and
written informed consent in accordance with the Declaration of Helsinki.
During the study period, 57 patients were admitted with respiratory symptoms, fever and coughing, and
assessed for eligibility. 33 patients met the inclusion criteria in terms of a radiological verification of
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pneumonia while 23 were excluded: six were unable to walk prior to hospitalisation, eight had been
hospitalised for >24 h, two had hospital-acquired pneumonia, and seven had a combination of
comorbidities (dementias and confusion) in addition to being deemed cognitively unable to adhere to and
collaborate with the FTPP programme and/or wearing the accelerometer. 10 eligible patients agreed to
participate and none of these patients involuntarily left the study prior to its conclusion. One patient died,
and one was admitted to the intensive care unit within the first 24 h after inclusion and was subsequently
withdrawn from further study assessments. The patient who died was necropsied, which showed a
pulmonary embolism due to previous radiation damage due to breast cancer.
Patient demographics (median 74 years) showed an overrepresentation by men (80%), which was
considered a random periodic outcome. 50% had a CURB-65 (confusion, urea >7 mmol·L−1, respiratory
rate ⩾30 breaths per min, blood pressure <90 mmHg (systolic) or ⩽60 mmHg (diastolic), age ⩾65 years))
score of two or more, indicating moderate to severe pneumonia. The patients’ habitual level of functioning
was reasonably good, with a self-reported BI-100 of 94. According to the FTPP tool, 87% of the patients
were reassessed for need for intravenous antibiotics within 72 h and the total time for intravenous
antibiotics was median 3.36 days. The median length of hospital stay was 4 days.
Daily documentation on the FTPP interdisciplinary tool by doctors, nurses and physiotherapists was
carried out 78% of the time. Based on the total number of day and night shifts documented, the
mobilisation care plan was applied 70% of the time. All patients were mobilised for ⩾20 min within 24 h
of admission. Moreover, patients had a documented level of activity level per shift that corroborates this.
The median observation time for patients in the project was 313 h (13 days) with a median adherence to
wearing the accelerometer of 269 h (79%). Summarised data showed that patients during hospitalisation
on average lied down for 10.08 h·day−1 (42%) with a slight increase during hospitalisation. At home, the
lying period was reduced to 8.4 h (35%) with a marginal increase in standing (figure 1b). The number of
steps per hour during the first 3 days of hospitalisation was remarkably low with an average of 56, 40 and
50 steps per h. At home, the average number of steps increased to 110 per h.
Total wear
time
Day 1
(n=10)
Day 2
(n=8)
Day 3
(n=8)
Total in
hospital
Total at
home
Lying
Sitting
Standing
Steps per h
34%
52%
14%
56
39%
48%
13%
40
43%
46%
10%
50
42%
49%
10%
58
35%
49%
16%
110
SF-12 subscale score#
a)
b)
c)
Physical component summary
Mental component summary
Physical functioning
Role physical
Bodily pain
General health
Vitality
Social functioning
Role emotional
Mental health
EQ-5D-5L¶
Mobility
Self-care
Usual activities
Anxiety/depression
Pain/discomfort
VAS#
Total score
Admission
(n=10)
34.6
44.06
39.9
33.88
34.16
37.37
39.37
40.44
38.28
45.9
2.6±1.26
1.9±0.99
2.6±1.58
1.8±0.92
2.6±1.43
52.4±19.7
Discharge
(n=8)
37.03
51.14
39.2
38.4
39.31
46.95
42.92
41.63
50.57
49.6
2.43±0.79
1.57±0.79
2.29±1.38
1.57±0.79
1.86±0.69
61.43±17.73
Follow up
(n=8)
38.84
48.41
37.51
40.21
47.45
41.26
42.59
39.98
43.3
52.65
2.5±0.93
1.88±1.25
2.5±1.95
1.25±0.71
1.7±0.71
69.38±13.89
FIGURE 1 a) Fast-track pneumonia pathway: an interdisciplinary tool. b) Mean body position times: lying, sitting and standing. c) Patient-reported
outcomes. Data are presented as mean±SD, unless otherwise stated. SF-12: 12-item Short Form Survey; EQ-5D-5L: five-dimension, five-level
EuroQol questionnaire; VAS: visual analogue scale. #: scored from 1 to 100, with a low score indicating severe problems; ¶: scored from 1 to 5,
with a high score indicating severe problems
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Most patients had various symptomatic and functional problems on admission (e.g. bodily pain, vitality
and role physical) with a slight improvement at follow-up. The EQ-5D-5L score ranged from 1.25 to 2.6,
with no scale showing any apparent difference over time, suggesting a relatively stable care independency.
The score on the total EQ-5D-5L visual analogue scale increased from 52.4 on admission to 69.38 at
follow-up, indicating an improvement in self-rated health (figure 1c).
Elderly patients with pneumonia often suffer from several comorbidities and competing disabilities [5]. In
the current feasibility study, several patients were excluded due to a lack of function and/or dementia and
cognitive dysfunctions, making them unable to participate in the accelerometer-based monitoring and
intervention. Despite this selection, and the fact that we may have included the healthiest participants with
pneumonia, the population still represent a very low level of physical activity during and after
hospitalisation with only slight improvement observed. This does strongly imply the need to emphasise
early mobilisation in cross-sectional care planning among this vulnerable population with significant risk
of mortality [3, 10, 11]. We hypothesise that the relatively large group of patients who were too frail to be
included should be offered and could benefit from a similar FTPP treatment course including an early
mobilisation care plan. This is supported by research that examines early mobilisation and the study of
patient progress in pneumonia treatment [10–14].
We conclude that structuring progressive patient mobilisation during complex clinical work conditions is
warranted, though application of advanced technology such as accelerometers may compromise study
feasibility. A stronger focus on research in this medical area is required to counteract hospital-induced
sedentarism and its immediate impact on daily functioning and subsequent major outcomes.
Lise Notander Clausen1, Mette Børgesen1, Pernille Ravn2 and Tom Møller 3
1Dept of Pulmonary and Infectious Diseases, Nordsjællands Hospital, Hillerød, Denmark. 2Dept of
Medical Diseases, Herlev and Gentofte Hospital, Copenhagen, Denmark. 3The University Hospitals Centre
for Health Research (UCSF), Copenhagen, Denmark.
Correspondence: Tom Møller, The University Hospitals Centre for Health Research (UCSF), Ryesgade 27,
Copenhagen N 2200, Denmark. E-mail: tom@ucsf.dk
Received: Oct 16 2018 | Accepted after revision: Jan 28 2019
Conflict of interest: None declared.
References
1 Flachs E, Eriksen L, Koch M. Sygdomsbyrden i Danmark – Sygdomme [The Burden of Disease in Denmark –
Diseases]. Copenhagen, Sundhedsstyrelsen, 2015.
2 Egelund GB, Jensen AV, Andersen SB, et al. Penicillin treatment for patients with community-acquired
pneumonia in Denmark: a retrospective cohort study. BMC Pulm Med 2017; 17: 66-017-0404-8.
3 Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia
in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–iii55.
4 Davydow DS, Hough CL, Levine DA, et al. Functional disability, cognitive impairment, and depression after
hospitalization for pneumonia. Am J Med 2013; 126: 615–624.
5 Klausen HH, Petersen J, Lindhardt T, et al. Outcomes in elderly Danish citizens admitted with
community-acquired pneumonia. Regional differences, in a public healthcare system. Respir Med 2012; 106:
1778–1787.
6 Kehlet H. Fast-track surgery – an update on physiological care principles to enhance recovery. Langenbecks Arch
Surg 2011; 396: 585–590.
7 Collin C, Wade DT, Davies S, et al. The Barthel ADL Index: a reliability study. Int Disabil Stud 1988; 10: 61–63.
8 Oemar M editor. EQ-5D-5L User Guide. 2nd Edn. Rotterdam, EuroQol, 2013.
9 Optum SF Health Surveys. SF-12v2 Health Survey. https://www.optum.com/solutions/life-sciences/answer-
research/patient-insights/sf-health-surveys/sf-12v2-health-survey.html
10 Ebell M. Does early mobilization improve outcomes in patients with community-acquired pneumonia? Evid Based
Pract 2003; 6: 9.
11 Carratala J, Garcia-Vidal C, Ortega L, et al. Effect of a 3-step critical pathway to reduce duration of intravenous
antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial. Arch
Intern Med 2012 Jun 25; 172: 922–928.
12 Hauck LD, Adler LM, Mulla ZD. Clinical pathway care improves outcomes among patients hospitalized for
community-acquired pneumonia. Ann Epidemiol 2004 Oct; 14: 669–675.
13 Mundy LM, Leet TL, Darst K, et al. Early mobilization of patients hospitalized with community-acquired
pneumonia. Chest 2003; 124: 883–889.
14 Holland BS. Pneumonia pathway reduces LOS and saves money. Hosp Case Manag 2000; 8: 151–154.
https://doi.org/10.1183/23120541.00012-2019 3
ORIGINAL RESEARCH LETTER | L.N. CLAUSEN ET AL.
